Floatz logo

60 assets in Acute Leukemia

Therapeutic assets addressing Acute Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fludarabine
Acute Leukemia
Sawa Ito, MDP2/3BB (69)
Cyclophosphamide
Acute Leukemia
Sawa Ito, MDP4BB (67)
Cytarabine
Acute Leukemia
Janssen Research & Development, LLCP2/3BB (66)
Busulfanum
Acute Leukemia
Sawa Ito, MDP4BB (65)
Adriamycin
Acute Leukemia
SWOG Cancer Research NetworkP2/3BB (64)
Etoposide
Acute Leukemia
SWOG Cancer Research NetworkP2/3BB (64)
Idarubicin
Acute Leukemia
Kura Oncology, Inc.P2/3BB (64)
Methotrexate
Acute Leukemia
SWOG Cancer Research NetworkP3BB (64)
Nivestim
Acute Leukemia
Kura Oncology, Inc.P2BB (64)
Prednisone
Acute Leukemia
SWOG Cancer Research NetworkP2BB (64)
Rituximab
Acute Leukemia
SWOG Cancer Research NetworkP2BB (64)
Tacrolimus
Acute Leukemia
Masonic Cancer Center, University of MinnesotaP3BB (64)
Cyclosporin A
Acute Leukemia
Fred Hutchinson Cancer CenterP2B (63)
Dexasone
Acute Leukemia
SWOG Cancer Research NetworkP2/3B (63)
Melphalan
Acute Leukemia
Center for International Blood and Marrow Transplant ResearchP2B (63)
Pegaspargase
Acute Leukemia
Janssen Research & Development, LLCP2/3B (62)
Tucidinostat
Acute Leukemia
The First Affiliated Hospital of Soochow UniversityP2/3B (62)
(+)-Vincristine
Acute Leukemia
SWOG Cancer Research NetworkP2/3B (62)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Acute Leukemia
Masonic Cancer Center, University of MinnesotaP2B (61)
Mesna
Acute Leukemia
Center for International Blood and Marrow Transplant ResearchP2B (61)
Palifermin
Acute Leukemia
Center for International Blood and Marrow Transplant ResearchP2B (60)
Thiotepa
Acute Leukemia
Sawa Ito, MDP2B (60)
Tretinoin
Acute Leukemia
SDK Therapeutics, Inc.P3B (60)
Arsenic Trioxide
Acute Leukemia
SDK Therapeutics, Inc.P3B (59)
Orca-T
Acute Leukemia
Orca Biosystems, Inc.P3B (59)
Flumatinib
Acute Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP4B (58)
Peripheral Blood Stem Cells, Allogeneic, Cd34 Positive
Acute Leukemia
Fred Hutchinson Cancer CenterP2B (58)
Imatinib
Acute Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP4B (57)
Sirolimus
Acute Leukemia
Ossium Health, Inc.P2B (57)
Ruxolitinib
Acute Leukemia
Center for International Blood and Marrow Transplant ResearchP2CCC (55)
Treosulfan
Acute Leukemia
Masonic Cancer Center, University of MinnesotaP2CCC (55)
Abatacept Recombinant
Acute Leukemia
Center for International Blood and Marrow Transplant ResearchP2CCC (53)
Larotrectinib
Acute Leukemia
Children's Oncology GroupP2CCC (53)
Ptcy
Acute Leukemia
Center for International Blood and Marrow Transplant ResearchP2CCC (53)
Apamistamab
Acute Leukemia
Actinium PharmaceuticalsP2/3CCC (52)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells
Acute Leukemia
Masonic Cancer Center, University of MinnesotaP2CCC (51)
Olverembatinib
Acute Leukemia
The First Affiliated Hospital of Soochow UniversityP2CCC (51)
Pbsc
Acute Leukemia
Fred Hutchinson Cancer CenterP2CCC (51)
BN104
Acute Leukemia
Institut de Recherches Internationales Servier (I.R.I.S.)P1/2CCC (48)
Patient Derived Cd19 Specific Car T Cells Also Expressing An Egfrt
Acute Leukemia
Seattle Children's HospitalP1/2CCC (48)
Revumenib
Acute Leukemia
Memorial Sloan Kettering Cancer CenterP1/2CCC (48)
Treg Cells
Acute Leukemia
Stanford UniversityP1/2CCC (48)
Vorinostat
Acute Leukemia
University of Michigan Rogel Cancer CenterP1/2CCC (48)
Tozinameran
Acute Leukemia
Assistance Publique - Hôpitaux de ParisP1/2CC (44)
Bleximenib
Acute Leukemia
Janssen Research & Development, LLCP1CC (43)
Jnj-75276617
Acute Leukemia
Janssen Research & Development, LLCP1CC (43)
lp-118
Acute Leukemia
University of ChicagoP1/2CC (43)
Mezigdomide
Acute Leukemia
Memorial Sloan Kettering Cancer CenterP1/2CC (43)
Petiveria Alliacea Preparation
Acute Leukemia
Hospital Universitario San IgnacioP1/2CC (43)
Ponatinib
Acute Leukemia
University of ChicagoP1/2CC (43)
Showing 1 to 50 of 60 assets
PreviousPage 1 of 2Next